RESUMO
The myotonic dystrophy (DM) mutation has recently been identified as an unstable trinucleotide CTG repeat which is present 5-30 times in the normal population but which is amplified up to 2,000 times in DM. We have determined the status of the CTG repeat in 272 DM individuals. Infants with severe congenital DM, as well as their mothers, are shown to have on average a greater amplification of the CTG repeat than is seen in the noncongenital DM population. This fact, when viewed in conjunction with the tendency to increased CTG repeat length in our DM kindreds, provides evidence for the existence of genetic anticipation in the transmission of DM.
Assuntos
Distrofia Miotônica/congênito , Distrofia Miotônica/genética , Sequências Repetitivas de Ácido Nucleico , Sequência de Bases , DNA/genética , Feminino , Amplificação de Genes , Humanos , Recém-Nascido , Desequilíbrio de Ligação , Masculino , Polimorfismo Genético , GravidezRESUMO
Myotonic dystrophy (DM) results from the amplification of an unstable CTG repeat in the 3' untranslated region of a transcript encoding a putative serine/threonine kinase. We have analysed the amplification of the repeat and the steady state levels of the DM kinase (DMK) mRNA in tissues and cell lines from normal and congenital DM individuals. Southern blot analysis of DNA samples from a severely affected neonate shows somatic heterogeneity of the repeat in all tissues studied. RNA analyses on these tissues show a marked increase in DMK steady state mRNA levels. We demonstrate that the mutant DMK allele is expressed regardless of the number of CTG repeats and that the increase in DMK mRNA levels is due to elevated mutant mRNA levels. We postulate that elevated DMK levels explains the dominant inheritance pattern of DM.
Assuntos
Distrofia Miotônica/genética , RNA Mensageiro/genética , Alelos , Sequência de Bases , DNA/genética , Amplificação de Genes , Expressão Gênica , Genes Dominantes , Humanos , Recém-Nascido , Dados de Sequência Molecular , Mutação , Distrofia Miotônica/congênito , Distrofia Miotônica/metabolismo , Oligodesoxirribonucleotídeos/genética , Proteínas Serina-Treonina Quinases/genética , RNA Mensageiro/metabolismo , Sequências Repetitivas de Ácido NucleicoRESUMO
During embryonic development, and in certain neurodegenerative diseases, neurons die by apoptosis. A new family of anti-apoptotic proteins, termed inhibitors of apoptosis (IAP), suppresses apoptosis through the direct inhibition of caspases. The anti-apoptotic activity of IAPs is inhibited by second mitochondria-derived activator of caspase (Smac)/DIABLO and XAF1 (ref. 8). IAPs, as well as neurotrophic factors, can protect degenerating neurons both in vivo and in vitro. However, the downstream targets of neurotrophic factors have not yet been identified. Here, we demonstrate that XIAP and NAIP, but not HIAP2, are directly involved in the intracellular response to glial cell-derived neurotrophic factor (GDNF). In newborn rats, GDNF regulates endogenous levels of XIAP and NAIP in motor neurons after sciatic nerve axotomy. The inhibition of XIAP or NAIP activity prevents GDNF-mediated neuroprotective effects. These results suggest that XIAP and NAIP are essential for intracellular signalling of GDNF in motor neuron survival.
Assuntos
Neurônios Motores/efeitos dos fármacos , Proteínas do Tecido Nervoso/metabolismo , Proteínas do Tecido Nervoso/farmacologia , Fármacos Neuroprotetores/farmacologia , Proteínas/metabolismo , Animais , Apoptose/fisiologia , Axotomia , Fator Neurotrófico Derivado do Encéfalo/farmacologia , Fator Neurotrófico Ciliar/farmacologia , Inibidores Enzimáticos/metabolismo , Fator Neurotrófico Derivado de Linhagem de Célula Glial , Humanos , Proteínas Inibidoras de Apoptose , Vértebras Lombares , Neurônios Motores/citologia , Neurônios Motores/metabolismo , Neurônios Motores/patologia , Fatores de Crescimento Neural/farmacologia , Proteínas do Tecido Nervoso/genética , Proteína Inibidora de Apoptose Neuronal , Proteínas/genética , Ratos , Ratos Sprague-Dawley , Nervo Isquiático/citologia , Nervo Isquiático/efeitos dos fármacos , Nervo Isquiático/cirurgia , Medula Espinal/citologia , Medula Espinal/metabolismo , Proteínas Inibidoras de Apoptose Ligadas ao Cromossomo XRESUMO
The inhibitors of apoptosis (IAPs) suppress apoptosis through the inhibition of the caspase cascade and thus are key proteins in the control of cell death. Here we have isolated the protein XIAP-associated factor 1 (XAF1) on the basis of its ability to bind XIAP, a member of the IAP family. XIAP suppresses caspase activation and cell death in vitro, and XAF1 antagonizes these XIAP activities. Expression of XAF1 triggers a redistribution of XIAP from the cytosol to the nucleus. XAF1 is ubiquitously expressed in normal tissues, but is present at low or undetectable levels in many different cancer cell lines. Loss of control over apoptotic signalling is now recognized as a critical event in the development of cancer. Our results indicate that XAF1 may be important in mediating the apoptosis resistance of cancer cells.
Assuntos
Caspases/metabolismo , Inibidores Enzimáticos/metabolismo , Proteínas de Neoplasias/metabolismo , Proteínas/antagonistas & inibidores , Proteínas Adaptadoras de Transdução de Sinal , Adenoviridae/genética , Adenoviridae/metabolismo , Animais , Antineoplásicos Fitogênicos/farmacologia , Apoptose/genética , Apoptose/fisiologia , Proteínas Reguladoras de Apoptose , Northern Blotting , Western Blotting , Inibidores de Caspase , Sobrevivência Celular , Meios de Cultura Livres de Soro , Etoposídeo/farmacologia , Genes Reporter , Humanos , Peptídeos e Proteínas de Sinalização Intracelular , Dados de Sequência Molecular , Proteínas de Neoplasias/genética , Plasmídeos/genética , Plasmídeos/metabolismo , Proteínas/genética , Proteínas/metabolismo , Proteínas Recombinantes de Fusão/genética , Proteínas Recombinantes de Fusão/metabolismo , Células Tumorais Cultivadas , Técnicas do Sistema de Duplo-Híbrido , Proteínas Inibidoras de Apoptose Ligadas ao Cromossomo X , Dedos de ZincoRESUMO
We show here that transient forebrain ischemia selectively elevates levels of neuronal apoptosis inhibitory protein (NAIP) in rat neurons that are resistant to the injurious effects of this treatment. This observation suggests that increasing NAIP levels may confer protection against ischemic cell death. Consistent with this proposal, we demonstrate that two other treatments that increase neuronal NAIP levels, systemic administration of the bacterial alkaloid K252a and intracerebral injection of an adenovirus vector capable of overexpressing NAIP in vivo, reduce ischemic damage in the rat hippocampus. Taken together, these findings suggest that NAIP may play a key role in conferring resistance to ischemic damage and that treatments that elevate neuronal levels of this antiapoptotic protein may have utility in the treatment of stroke.
Assuntos
Hipocampo/lesões , Hipocampo/metabolismo , Ataque Isquêmico Transitório/metabolismo , Proteínas do Tecido Nervoso/metabolismo , Adenoviridae/genética , Animais , Apoptose/efeitos dos fármacos , Apoptose/fisiologia , Carbazóis/administração & dosagem , Carbazóis/uso terapêutico , Expressão Gênica/efeitos dos fármacos , Terapia Genética , Vetores Genéticos , Hipocampo/irrigação sanguínea , Alcaloides Indólicos , Ataque Isquêmico Transitório/patologia , Ataque Isquêmico Transitório/terapia , Masculino , Fatores de Crescimento Neural/administração & dosagem , Fatores de Crescimento Neural/uso terapêutico , Proteínas do Tecido Nervoso/genética , Proteína Inibidora de Apoptose Neuronal , Neurônios/efeitos dos fármacos , Neurônios/metabolismo , Neurônios/patologia , Ratos , Ratos WistarRESUMO
The cellular inhibitor of apoptosis 1 and 2 (cIAP1 and cIAP2) proteins have been implicated in the activation of NF-kappaB by TNFalpha; however, genetic deletion of either cIAP1 or 2 did not support a physiologically relevant role, perhaps because of functional redundancy. To address this, we used combined genetic and siRNA knockdown approaches and report that cIAP1 and 2 are indeed critical, yet redundant, regulators of NF-kappaB activation upon TNFalpha treatment. Whereas NF-kappaB was properly activated by TNFalpha in cultured and primary cells deficient in either cIAP1 or 2, removal of both cIAPs severely blunted its activation. After treatment with TNFalpha, cIAP1 and 2 were rapidly recruited to the TNF receptor 1, along with the adapter protein TNF receptor associated factor 2. Importantly, either cIAP1 or 2 was required for proper TNF receptor 1 signalosome function. In their combined absence, polyubiquitination of receptor interacting protein 1, an upstream event necessary for NF-kappaB signaling, was attenuated. As a result, phosphorylation of the inhibitor of kappaB kinase beta was diminished, and signal transduction was severely blunted. Consequently, cells missing both cIAP1 and 2 were sensitized to TNFalpha-mediated apoptosis. Collectively, these data demonstrate that either cIAP1 or 2 is required for proper Rip1 polyubiquitination and NF-kappaB activation upon TNFalpha treatment.
Assuntos
Proteínas Inibidoras de Apoptose/metabolismo , NF-kappa B/metabolismo , Fator de Necrose Tumoral alfa/farmacologia , Animais , Apoptose/efeitos dos fármacos , Células Cultivadas , Proteínas Ativadoras de GTPase/metabolismo , Proteínas Inibidoras de Apoptose/deficiência , Proteínas Inibidoras de Apoptose/genética , Camundongos , Camundongos Knockout , Mioblastos/efeitos dos fármacos , Mioblastos/metabolismo , Transdução de Sinais/efeitos dos fármacos , Proteína de Domínio de Morte Associada a Receptor de TNF/metabolismo , UbiquitinaçãoRESUMO
Myotonic dystrophy (DM) is an autosomal-dominant disorder that affects 1 in 8000 individuals. Amplification of an unstable trinucleotide CTG repeat, located within the 3' untranslated region of a gene, correlates with a more severe DM phenotype. In three cases, the number of CTG repeats was reduced during the transmission of the DM allele; in one of these cases, the number was reduced to within the normal range and correlated at least with a delay in the onset of clinical signs of DM. Haplotype data of six polymorphic markers in the DM gene region indicate that, in this latter case, two stretches of the affected chromosome had been exchanged with that region of the wild-type chromosome.
Assuntos
Cromossomos Humanos Par 19 , Mutação , Distrofia Miotônica/genética , Polimorfismo de Fragmento de Restrição , Sequências Repetitivas de Ácido Nucleico , Adulto , Fatores Etários , Alelos , Apolipoproteína C-II , Apolipoproteínas C/genética , Sequência de Bases , DNA/genética , DNA/isolamento & purificação , Feminino , Genes Dominantes , Haplótipos , Humanos , Masculino , Dados de Sequência Molecular , Distrofia Miotônica/fisiopatologia , Oligodesoxirribonucleotídeos , Linhagem , Reação em Cadeia da PolimeraseRESUMO
Tumor necrosis factor alpha (TNF-alpha) binding to the TNF receptor (TNFR) potentially initiates apoptosis and activates the transcription factor nuclear factor kappa B (NF-kappaB), which suppresses apoptosis by an unknown mechanism. The activation of NF-kappaB was found to block the activation of caspase-8. TRAF1 (TNFR-associated factor 1), TRAF2, and the inhibitor-of-apoptosis (IAP) proteins c-IAP1 and c-IAP2 were identified as gene targets of NF-kappaB transcriptional activity. In cells in which NF-kappaB was inactive, all of these proteins were required to fully suppress TNF-induced apoptosis, whereas c-IAP1 and c-IAP2 were sufficient to suppress etoposide-induced apoptosis. Thus, NF-kappaB activates a group of gene products that function cooperatively at the earliest checkpoint to suppress TNF-alpha-mediated apoptosis and that function more distally to suppress genotoxic agent-mediated apoptosis.
Assuntos
Apoptose , Caspases , Cisteína Endopeptidases/metabolismo , NF-kappa B/metabolismo , Proteínas/genética , Animais , Caspase 3 , Caspase 8 , Caspase 9 , Grupo dos Citocromos c/metabolismo , Ativação Enzimática , Etoposídeo/farmacologia , Regulação da Expressão Gênica , Humanos , Proteínas Inibidoras de Apoptose , Mitocôndrias/metabolismo , Proteínas/fisiologia , Transdução de Sinais , Fator 1 Associado a Receptor de TNF , Fator 2 Associado a Receptor de TNF , Células Tumorais Cultivadas , Fator de Necrose Tumoral alfa/farmacologia , Ubiquitina-Proteína LigasesRESUMO
Detachment of normal epithelial cells from the extracellular matrix triggers apoptosis, a phenomenon called anoikis. Conversely, carcinoma cells tend to be relatively more anoikis-resistant than their normal counterparts, and this increased resistance represents a critical feature of the malignant phenotype. Mechanisms that control susceptibility and resistance to anoikis are not fully understood. It is now known that detachment of non-malignant epithelial cells triggers both pro- and antiapoptotic signals, and it is the balance between these signals and the duration of detachment that determine further fate of the cells. Detachment-induced antiapoptotic events delay anoikis and if cells reattach relatively soon after detachment they survive. Direct regulators of apoptosis responsible for this delay of anoikis are unknown. We found that detachment of non-malignant intestinal epithelial cells triggers upregulation of inhibitors of apoptosis protein (IAP) family, such as X-chromosome-linked inhibitor of apoptosis protein and cellular inhibitor of apoptosis-2 (cIAP2). We demonstrated that this upregulation requires detachment-dependent activation of the transcription factor nuclear factor-kappaB. We further observed that various IAP antagonists accelerate anoikis, indicating that upregulation of the IAPs delays detachment-triggered apoptosis. We conclude that the IAPs are important regulators of the balance between detachment-triggered life and death signals. Perhaps, not by coincidence, these proteins are often upregulated in carcinomas, tumors composed of cells that tend to be anoikis-resistant.
Assuntos
Anoikis , Proteínas Inibidoras de Apoptose/fisiologia , Mucosa Intestinal/patologia , Proteínas Inibidoras de Apoptose Ligadas ao Cromossomo X/fisiologia , Proteína 3 com Repetições IAP de Baculovírus , Células Cultivadas , Matriz Extracelular/fisiologia , Humanos , Proteínas Inibidoras de Apoptose/antagonistas & inibidores , Proteínas Inibidoras de Apoptose/genética , NF-kappa B/fisiologia , Ubiquitina-Proteína Ligases , Regulação para Cima , Proteínas Inibidoras de Apoptose Ligadas ao Cromossomo X/antagonistas & inibidores , Proteínas Inibidoras de Apoptose Ligadas ao Cromossomo X/genética , Proteína bcl-X/genética , Proteína bcl-X/fisiologiaRESUMO
The majority of cellular stresses lead to the inhibition of cap-dependent translation. Some mRNAs, however, are translated by a cap-independent mechanism, mediated by ribosome binding to internal ribosome entry site (IRES) elements located in the 5' untranslated region. Interestingly, IRES elements are found in the mRNAs of several survival factors, oncogenes and proteins crucially involved in the control of apoptosis. These mRNAs are translated under a variety of stress conditions, including hypoxia, serum deprivation, irradiation and apoptosis. Thus, IRES-mediated translational control might have evolved to regulate cellular responses in acute but transient stress conditions that would otherwise lead to cell death.
Assuntos
Apoptose/fisiologia , Modelos Genéticos , Biossíntese de Proteínas , Ribossomos/fisiologia , Regiões 5' não Traduzidas , Hipóxia Celular , Sobrevivência Celular , Meios de Cultura Livres de Soro , Raios gama , Substâncias Macromoleculares , Fatores de Alongamento de Peptídeos/fisiologia , Fatores de Iniciação de Peptídeos/fisiologia , Picornaviridae/genética , Biossíntese de Proteínas/efeitos da radiação , Isoformas de Proteínas/fisiologia , Capuzes de RNA/fisiologia , RNA Mensageiro/genética , RNA Viral/genética , Sequências Reguladoras de Ácido NucleicoRESUMO
X-linked inhibitor of apoptosis protein (XIAP) is a key regulator of programmed cell death triggered by various apoptotic triggers. Translation of XIAP is controlled by a 162-nucleotide (nt) internal ribosome entry site (IRES) element located in the 5' untranslated region of XIAP mRNA. XIAP IRES mediates efficient translation of XIAP under physiological stress and enhances cell protection against serum deprivation and radiation-induced apoptosis. In the present report we describe the assembly of a sequence-specific RNA-protein complex consisting of at least four cytosolic proteins on the XIAP IRES element. We determine that the core binding sequence is approximately 28 nt long and is located 34 nt upstream of the initiation site. Moreover, we identify the La autoantigen as a protein that specifically binds XIAP IRES in vivo and in vitro. The biological relevance of this interaction is further demonstrated by the inhibition of XIAP IRES-mediated translation in the absence of functional La protein. The results suggest an important role for the La protein in the regulation of XIAP expression, possibly by facilitating ribosome recruitment to the XIAP IRES.
Assuntos
Autoantígenos/metabolismo , Proteínas de Ligação a DNA , Ribonucleoproteínas Nucleares Heterogêneas , Biossíntese de Proteínas , Proteínas/genética , Sequências Reguladoras de Ácido Nucleico , Ribonucleoproteínas/metabolismo , Sequência de Bases , Humanos , Dados de Sequência Molecular , Proteína de Ligação a Regiões Ricas em Polipirimidinas , Proteínas/metabolismo , RNA Mensageiro/metabolismo , Proteínas de Ligação a RNA/genética , Proteínas de Ligação a RNA/metabolismo , Ribossomos/genética , Fatores de Transcrição/metabolismo , Proteínas Inibidoras de Apoptose Ligadas ao Cromossomo X , Antígeno SS-BAssuntos
Sobrevivência Celular/fisiologia , Proteínas/genética , Proteínas/metabolismo , Ribossomos/metabolismo , Células 3T3 , Regiões 5' não Traduzidas/genética , Animais , Morte Celular , Linhagem Celular , Cloranfenicol O-Acetiltransferase/genética , Cloranfenicol O-Acetiltransferase/metabolismo , Células HeLa , Humanos , Camundongos , Biossíntese de Proteínas , RNA Mensageiro/genética , Proteínas Recombinantes de Fusão/metabolismo , Transcrição Gênica , Transfecção , Proteínas Inibidoras de Apoptose Ligadas ao Cromossomo X , beta-Galactosidase/genética , beta-Galactosidase/metabolismoRESUMO
Inhibitory regulators of apoptosis play a critical role in the responsiveness of tumour cells to cytotoxic agents. The X-linked inhibitor of apoptosis protein (XIAP) is a member of a novel family of Inhibitor of Apoptosis (IAP) proteins. Here we show that acute low dose ionizing irradiation results in the translational upregulation of XIAP that correlates with an increased resistance to radiation in non-small cell lung carcinoma. This upregulation is mediated by an internal ribosome binding mechanism via an IRES element located within a XIAP 5' UTR. Transient overexpression of XIAP rendered human carcinoma cells resistant to low dose gamma-irradiation. By contrast, the antisense targeting of XIAP resulted in increased cell death following irradiation advocating a distinct role for XIAP in radiation resistant phenotype of human cancers. Oncogene (2000) 19, 4174 - 4177
Assuntos
Apoptose , Raios gama , Proteínas/metabolismo , Regiões 5' não Traduzidas , Elementos Antissenso (Genética) , Humanos , Biossíntese de Proteínas , Proteínas/genética , Ribossomos/genética , Células Tumorais Cultivadas , Regulação para Cima , Proteínas Inibidoras de Apoptose Ligadas ao Cromossomo XRESUMO
The inhibitor of apoptosis protein family has been characterized over the past 5 years, initially in baculovirus and more recently in metazoans. The IAPs are a widely expressed gene family of apoptotic inhibitors from both phylogenic and physiologic points of view. The diversity of triggers against which the IAPs suppress apoptosis is greater than that observed for any other family of apoptotic inhibitors including the bcl-2 family. The central mechanisms of IAP apoptotic suppression appear to be through direct caspase and pro-caspase inhibition (primarily caspase 3 and 7) and modulation of and by the transcription factor NF-kappaB. Although evidence for a direct oncogenic role for the IAPs has yet to be delineated, a number of lines of evidence point towards this class of protein playing a role in oncogenesis. The strongest evidence for IAP involvement in cancer is seen in the IAP called survivin. Although not observed in adult differentiated tissue, survivin is present in most transformed cell lines and cancers tested to date. Survivin has been shown to inhibit caspase directly and apoptosis in general, moreover survivin protein levels correlate inversely with 5 year survival rates in colorectal cancer. Recent data has also implicated survivin in cell cycle control. The second line of evidence for IAP involvement in cancer comes from their emerging role as mediators and regulators of the anti-apoptotic activity of v-Rel and NF-kappaB transcription factor families. The IAPs have been shown to be induced by NF-kappaB or v-Rel in multiple cell lines and conversely, HIAP1 and HIAP2 have been shown to activate NF-kappaB possibly forming a positive feed-back loop. Overall a picture consistent with an IAP role in tumour progression rather than tumour initiation is emerging making the IAPs an attractive therapeutic target.
Assuntos
Apoptose , Proteínas Associadas aos Microtúbulos , Neoplasias/genética , Proteínas/fisiologia , Sequência de Aminoácidos , Animais , Caspases/efeitos dos fármacos , Caspases/metabolismo , Regulação Neoplásica da Expressão Gênica , Humanos , Proteínas Inibidoras de Apoptose , Dados de Sequência Molecular , NF-kappa B/fisiologia , Proteínas de Neoplasias , Neoplasias/patologia , Proteínas Oncogênicas v-rel , Biossíntese de Proteínas , Proteínas Tirosina Quinases , Proteínas/metabolismo , Proteínas Oncogênicas de Retroviridae/fisiologia , Homologia de Sequência de Aminoácidos , Survivina , Fatores de Transcrição , Ubiquitina-Proteína Ligases , Proteínas Virais/fisiologia , Dedos de ZincoRESUMO
Transient forebrain ischemia produced by four-vessel occlusion (4-VO) triggers the delayed death of CA1 neurons in the hippocampus, resulting in behavioral deficits of spatial learning performance. We demonstrate that CA1 neuronal loss induced by 4-VO (12 min) is preceded by a selective and marked elevation of catalytically active caspase-3 in these neurons, indicative of apoptosis. Virally mediated overexpression of the anti-apoptotic gene X chromosome-linked inhibitor of apoptosis protein (XIAP) prevented both the production of catalytically active caspase-3 and degeneration of CA1 neurons after transient forebrain ischemia. CA1 neurons protected in this manner appeared to function normally, as assessed by immunohistochemical detection of the neuronal activity marker nerve growth factor inducible-A and by spatial learning performance in the Morris water maze. These findings indicate that caspase-3 activation is a key event in ischemic neuronal death and that blockade of this event by XIAP overexpression permits CA1 neurons to survive and operate properly after an ischemic insult.
Assuntos
Apoptose/genética , Hipocampo/citologia , Ataque Isquêmico Transitório/fisiopatologia , Proteínas do Tecido Nervoso/genética , Cromossomo X , Animais , Comportamento Animal/fisiologia , Química Encefálica/genética , Caspase 3 , Caspases/metabolismo , Fragmentação do DNA , Regulação Enzimológica da Expressão Gênica/fisiologia , Hipocampo/irrigação sanguínea , Hipocampo/química , Masculino , Aprendizagem em Labirinto/fisiologia , Proteína Inibidora de Apoptose Neuronal , Neurônios/química , Neurônios/citologia , Neurônios/enzimologia , Proteínas/genética , Ratos , Ratos Wistar , Proteínas Inibidoras de Apoptose Ligadas ao Cromossomo XRESUMO
Rhabdomyosarcoma (RMS), a neoplasm characterised by undifferentiated myoblasts, is the most common soft tissue tumour of childhood. Although aggressive treatment of RMS could provide long-term benefit, resistance to current therapies is an ongoing problem. We report here that insulin-like growth factor 2-binding protein 1 (IGF2BP1), an oncofetal protein, is expressed in RMS patient-derived cell lines and in primary tumours where it drives translation of the cellular inhibitor of apoptosis 1 (cIAP1), a key regulator of the nuclear factor-κB signalling pathway and of caspase-8-mediated cell death. We demonstrate that reducing the levels of cIAP1 in RMS, either by IGF2BP1 knockdown or by IAP antagonists, sensitises these cells to tumour necrosis factor-α-mediated cell death. Finally, we show that targeting cIAP1 by IAP antagonists delays RMS tumour growth and improve survival in mice. Our results identify IGF2BP1 as a critical translational regulator of cIAP1-mediated apoptotic resistance in RMS and advocate for the combined use of IAP antagonists and tumour necrosis factor-α as a therapeutic approach for this type of cancer.
Assuntos
Resistencia a Medicamentos Antineoplásicos , Proteínas Inibidoras de Apoptose/genética , Proteínas de Ligação a RNA/metabolismo , Rabdomiossarcoma/metabolismo , Alcinos/farmacologia , Animais , Apoptose , Linhagem Celular Tumoral , Dipeptídeos/farmacologia , Feminino , Regulação Neoplásica da Expressão Gênica , Células HEK293 , Humanos , Proteínas Inibidoras de Apoptose/metabolismo , Camundongos , Camundongos Nus , Transplante de Neoplasias , Biossíntese de Proteínas , Proteínas de Ligação a RNA/antagonistas & inibidores , Rabdomiossarcoma/tratamento farmacológico , Transdução de Sinais , Tiazóis/farmacologia , Fator de Necrose Tumoral alfa/metabolismo , Ubiquitina-Proteína LigasesRESUMO
The inhibitor of apoptosis proteins (IAPs) constitute a family of highly conserved apoptosis suppressor proteins that was originally identified in baculoviruses. Although IAP homologs have been recently identified and demonstrated to suppress apoptosis in mammalian cells, their expression and role during follicular development and atresia are unknown. The present study was conducted to address these questions. Using established in vivo models for the induction of follicular development and atresia in immature rats, it was possible to compare the immunolocalization of X-link inhibitor of apoptosis protein (Xiap) and human inhibitor of apoptosis protein-2 (Hiap-2), two members of the IAP family, at defined stages of follicular maturation and to relate the differences observed with those of follicular cell proliferation and apoptosis [as determined by proliferating cell nuclear antigen (PCNA) immunohistochemistry and in situ terminal deoxynucleotidyl transferase-mediated dUTP-biotin end labeling (TUNEL), respectively]. In addition, granulosa cell DNA and proteins were assessed for apoptotic fragmentation by 3'-end labeling/agarose gel electrophoresis (DNA ladder) and Hiap-2 and Xiap protein content by Western blot analysis, respectively. Hiap-2 and Xiap expression in both granulosa and theca cells increased with follicular maturation, reaching maximal levels at the antral stage of development. The immunoreactivity for PCNA, Xiap, and Hiap-2 decreased markedly in atretic (TUNEL-positive) follicles at the small to medium sized antral stage of development, suggesting follicular atresia may be associated with decreased granulosa cell IAP protein content and decreased proliferation. Atresia was also associated with a change in the intracellular distribution of IAPs in granulosa cells. Biochemical analysis of DNA fragmentation (DNA ladder) in granulosa cells from preantral and early antral follicles indicates extensive apoptosis that was associated with minimal IAP protein content. Gonadotropin treatment increased Hiap-2 and Xiap protein content and suppressed apoptosis in granulosa cells, resulting in the development of follicles to the antral and preovulatory stages. In addition, gonadotropin withdrawal induced apoptotic DNA fragmentation in granulosa cells in early antral and antral follicles, which is accompanied by a marked decrease in Hiap-2 and Xiap expression. These data suggest that IAPs may be involved in the suppression of granulosa cell apoptosis by gonadotropin in small to medium-sized antral follicles and play an important role in determining the fate of the cells, and thus also the eventual follicular destiny (atresia vs. ovulation).
Assuntos
Apoptose/efeitos dos fármacos , Atresia Folicular/metabolismo , Células da Granulosa/química , Folículo Ovariano/fisiologia , Proteínas/análise , Animais , Fragmentação do DNA , Feminino , Imuno-Histoquímica , Antígeno Nuclear de Célula em Proliferação/análise , Ratos , Ratos Sprague-Dawley , Receptores do Fator de Necrose Tumoral/fisiologia , Proteínas Inibidoras de Apoptose Ligadas ao Cromossomo XRESUMO
The inhibitor of apoptosis proteins (IAPs) constitutes a family of highly conserved apoptosis suppressor proteins that were originally identified in baculoviruses. Although IAP homologs have recently been demonstrated to suppress apoptosis in mammalian cells, their expression and role in human ovarian epithelial cancer and chemotherapy resistance are unknown. In the present study we used cisplatin-sensitive and -resistant human ovarian surface epithelial (hOSE) cancer cell lines and adenoviral antisense and sense complementary DNA expression to examine the role of IAP in the regulation of apoptosis in human ovarian cancer cells and chemoresistance. Antisense down-regulation of X-linked inhibitor of apoptosis protein (Xiap), but not human inhibitor of apoptosis protein-2 (Hiap-2), induced apoptosis in cisplatin-sensitive and, to a lesser extent, in -resistant cells. Cisplatin consistently decreased Xiap content and induced apoptosis in the cisplatin-sensitive, but not cisplatin-resistant, cells. Hiap-2 expression was either unaffected or inhibited to a lesser extent. The inhibition of IAP protein expression and induction of apoptosis by cisplatin was time and concentration dependent. Infection of cisplatin-sensitive cells with adenoviral sense Xiap complementary DNA resulted in overexpression of Xiap and markedly attenuated the ability of cisplatin to induce apoptosis. Immunohistochemical localization of the IAPs in hOSE tumors demonstrated the presence of Xiap and Hiap-2, with their levels being highest in proliferative, but not apoptotic, epithelial cells. These studies indicate that Xiap is an important element in the control of ovarian tumor growth and may be a point of regulation for cisplatin in the induction of apoptosis. These results suggest that the ability of cisplatin to down-regulate Xiap content may be an important determinant of chemosensitivity in hOSE cancer.